Sign up to save your podcasts
Or
Share Intact CEO Bruce Shook Excited by New Round, Clinical Progress, and the Potential for Spin-off, Vesper
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Intact CEO Bruce Shook Excited by New Round, Clinical Progress, and the Potential for Spin-off, Vesper
Intact Vascular recently secured an additional $20m to push the Tack Endovascular System to PMA approval. CEO Bruce Shook discusses the round, the potential for Tack, and shares that he's actually the CEO of TWO Medtech start-ups.
View all episodes
By Healthegy
4.8
5959 ratings
Intact Vascular recently secured an additional $20m to push the Tack Endovascular System to PMA approval. CEO Bruce Shook discusses the round, the potential for Tack, and shares that he's actually the CEO of TWO Medtech start-ups.
More shows like Medtech Talk
View all
All-In with Chamath, Jason, Sacks & Friedberg
10,015 Listeners